Cocrystal pharma reports first quarter 2022 financial results and provides updates on its antiviral development programs and milestones

Bothell, wash., may 11, 2022 (globe newswire) -- cocrystal pharma, inc. (nasdaq: cocp) reports financial results for the three months ended march 31, 2022, and provides updates on its antiviral pipeline, upcoming milestones and business activities.
COCP Ratings Summary
COCP Quant Ranking